Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-16.50%
Changement Mensuel
-9.47%
Evolution sur 6 mois
-16.50%
Changement Annuel
-20.74%
Clôture Précédente
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
Volume
15
Marchés
Actions des Marchés US
Soins de Santé
SEER
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
383.42 M
366.6 M
347.26 M
322.49 M
308.61 M
Total liabilities
38.7 M
39.03 M
36.26 M
34.2 M
36.79 M
Total equity
344.73 M
327.57 M
311.01 M
288.29 M
271.81 M
Total liabilities & shareholders' equities
383.42 M
366.6 M
347.26 M
322.49 M
308.61 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
Nouvelles
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer: база установок выросла на 67%, выручка не оправдала ожиданий
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Seer: доходы побили прогнозы, прибыльa оказался ниже прогнозов в Q4
Seer earnings beat by $0.02, revenue fell short of estimates
Seer представит технологию протеомики на конференции US HUPO
Seer to showcase proteomics technology at US HUPO conference
Исследование масс-спектрометрии подтверждает связи белок-ген для разработки лекарств
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer на форуме CG MedTech: инновации в протеомике указывают путь